Inger L. Rosner
Impact in
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Prostate Cancer Diagnosis and Treatment 27
- Prostate Cancer Treatment and Research 24
- Renal cell carcinoma treatment 3
-
- Renal and related cancers 3
- Co-authors
- David G. McLeod (19 shared papers)Jennifer Cullen (25 shared papers)Shiv Srivastava (27 shared papers)Yongmei Chen (25 shared papers)Isabell A. Sesterhenn (24 shared papers)Timothy C. Brand (15 shared papers)Jennifer Cullen (15 shared papers)Amina Ali (8 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)The Journal of Urology (9 papers)Cancer Research (7 papers)Urologic Oncology Seminars and Original Investigations (6 papers)Cancer Medicine (3 papers)
- Partner nations
- United StatesPakistanDenmark
In The Last Decade
Inger L. Rosner
67 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 85
- Pulmonary and Respiratory Medicine 682
- Cancer Research 229
- Oncology 134
- Molecular Medicine 21
- Molecular Biology 257
Countries citing papers authored by Inger L. Rosner
This map shows the geographic impact of Inger L. Rosner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger L. Rosner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger L. Rosner more than expected).
Fields of papers citing papers by Inger L. Rosner
This network shows the impact of papers produced by Inger L. Rosner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger L. Rosner. The network helps show where Inger L. Rosner may publish in the future.
Co-authors
The 25 scholars most cited alongside Inger L. Rosner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 242 | |
| 2 | 2009 | 52 | |
| 3 | 2018 | 47 | |
| 4 | 2015 | 46 | |
| 5 | Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy. | 2011 | 43 |
| 6 | 2017 | 41 | |
| 7 | 2015 | 38 | |
| 8 | 2013 | 36 | |
| 9 | 2019 | 35 | |
| 10 | 2015 | 34 | |
| 11 | 2019 | 33 | |
| 12 | 2014 | 33 | |
| 13 | 2020 | 33 | |
| 14 | 2011 | 31 | |
| 15 | 2005 | 27 | |
| 16 | 2007 | 25 | |
| 17 | 2009 | 23 | |
| 18 | 2015 | 21 | |
| 19 | 2014 | 20 | |
| 20 | 2020 | 20 |
About Inger L. Rosner
Inger L. Rosner is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 69 papers that have together received 1.1k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (27 papers), Prostate Cancer Treatment and Research (24 papers), Cancer, Lipids, and Metabolism (8 papers), Cancer, Hypoxia, and Metabolism (4 papers), Renal cell carcinoma treatment (3 papers), Renal and related cancers (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (682 citations), Cancer Research (229 citations), Oncology (134 citations), Molecular Medicine (21 citations) and Molecular Biology (257 citations). Inger L. Rosner has collaborated with scholars based in United States, Pakistan and Denmark. Frequent co-authors include David G. McLeod, Jennifer Cullen, Shiv Srivastava, Yongmei Chen, Isabell A. Sesterhenn, Timothy C. Brand, Jennifer Cullen, Amina Ali, H. Jeffrey Lawrence and Nan Zhang. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Cancer Research, Urologic Oncology Seminars and Original Investigations and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.